Home > Company > News

News

Welcome to the OpGen News page, home to the most recent information about new OpGen developments, products and services. For background on OpGen, please see also our Company Overview  and Investor Relations pages; for the latest company updates, read our most recent press releases and announcements, below.

Media Inquiries

Judy Macemon, VP, Marketing
OpGen, Inc.
708 Quince Orchard Road
Gathersburg, Maryland 20878 USA
info@OpGen.com
P  240.813.1289

Investor Inquiries

Eric Winzer, CFO
OpGen, Inc.
InvestorRelations@OpGen.com
P  240.813.1289

Press Releases and Announcements

All OpGen press releases are issued in the United States. Press releases reflect current information at the time of issuance and therefore may not reflect present developments.

2/14/12 OpGen Demonstrates Whole Human Chromosome Mapping Capabilities at 2012 AGBT Meeting
01/17/12 OpGen’s Whole Genome Mapping System and Genome-Builder™ Software Suite Featured at the International Plant & Animal Genome XX Conference
12/20/11 OpGen Strengthens Management Team to Accelerate Commercialization Strategy
10/13/11 OpGen Announces Launch of Genome-Builder, a Breakthrough Advance for Sequence Assembly and Structure Variation Analysis in Large Genomes
10/11/11 OpGen’s Whole Genome Mapping Technology Provides Critical Genomic Information for Malaria Research
8/18/11 Frost & Sullivan New Product Innovation Award Recognizes OpGen’s Argus® Whole Genome Mapping System
6/13/11 Optical Mapping First to Definitively Determine Deadly E. coli Strains in German Outbreak Are From a Single Source and Related to Earlier Outbreaks
5/23/11 The University of Maryland Institute for Genome Sciences (IGS) and OpGen, Inc Announce Collaboration to Develop Microbial Sequence Database
2/8/11 OpGen Announces Argus® Optical Mapping System Purchase by BGI
1/6/11 OpGen Announces Argus® Optical Mapping System Purchase by Wellcome Trust Sanger Institute
11/30/10 OpGen, Inc., to Present at the Piper Jaffray 22nd Annual Health Care Conference
11/4/10 BGI and OpGen Collaborate on Use of Optical Mapping for Whole Genome Assembly
9/27/10 OpGen Completes $17 Million Series B Financing

Awards

OpGen, Inc. Receives Frost & Sullivan New Product Innovation Award

OpGen, Inc., a provider of innovative whole genome DNA analysis solutions, announced today the company was chosen to receive the Frost & Sullivan 2011 Best Practice Award for New Product Innovation. The annual Frost & Sullivan awards spotlight “best-in-class” companies based on excellence in managing growth, innovation and leadership, and are selected utilizing Frost & Sullivan’s global research organization of 1,800 analysts and consultants monitoring 300 industries and 250,000 companies. “The New Product Innovation Award recognizes the most innovative, market-changing technologies in the life science community,” notes industry analyst Christi Bird. “We expect OpGen’s Argus® System to become a vital tool in sequencing laboratories to drive efficiency and reduce costs of genome finishing.”

OpGen, Inc. Receives Incubator Company of the Year Award

In recognition of businesses across the county that have shown steadfast commitment to business growth, job creation, workforce training and development, disability hiring, environmental health and personal achievement, OpGen, Inc. was selected as the 2008 Incubator Company of the Year by Montgomery County Maryland’s Department of Economic Development. The award was presented by award-winning FOX5 news anchor Shawn Yancy in the October award ceremony. County Executive Isiah Leggett stated in his closing commentary regarding the award recipients, “…they truly reflect the excellence, diversity and entrepreneurial spirit that exist in Montgomery county’s workforce and business community.”